Grigorios Korosoglou | Health Professions | Best Paper Award

Best Paper Award

State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach

Grigorios Korosoglou
Affiliation GRN Hospital Weinheim
Country Germany
Article Title State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach
Scopus ID 6507894424
Article Type Review Article
Article Views 1102
Reference Count 34
Award Category Best Paper Award
Event International Research Excellence and Best Paper Awards
ORCID 0000-0002-6038-2253

The Best Paper Award recognizes the scholarly contribution of Grigorios Korosoglou for the publication titled State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach. The article contributes to contemporary cardiovascular and vascular intervention research by examining evidence-based treatment pathways for femoropopliteal lesions and presenting a structured clinical decision framework. The work reflects the integration of clinical expertise, systematic evaluation, and translational application within health professions research, supporting improved patient management and procedural outcomes in vascular medicine.[1]

Abstract

This award-recognized article examines definitive treatment strategies for femoropopliteal arterial lesions through a structured case-based framework. The study evaluates current endovascular and adjunctive therapeutic approaches, emphasizing lesion characteristics, patient-specific risk factors, procedural planning, and long-term vessel patency. By integrating contemporary evidence with clinical decision-making principles, the publication provides guidance for selecting appropriate interventions in complex peripheral artery disease cases. The work highlights evolving technologies, procedural optimization, and outcome assessment while supporting individualized treatment pathways. Its findings contribute to improved understanding of therapeutic selection and clinical management within modern vascular medicine and cardiovascular intervention practice.[2]

Keywords

Definitive Lesion Treatment; Case-Based Approach; Femoropopliteal Lesions; Chronic Total Occlusions (CTOs); Drug-Coated Balloon Angioplasty (DCB); Bare-Metal Stents (BMSs); Drug Eluting Stents (DESs); Interwoven Stents.

Introduction

Peripheral artery disease remains a significant contributor to morbidity worldwide, particularly among aging populations and individuals with cardiovascular risk factors. Femoropopliteal lesions present unique treatment challenges because of vessel movement, lesion complexity, and the need for durable long-term outcomes. Contemporary research increasingly focuses on refining therapeutic strategies that balance procedural success, patient safety, and sustained vascular patency while incorporating advances in endovascular technologies and evidence-based clinical practice.[3]

Research Profile

Grigorios Korosoglou is affiliated with GRN Hospital Weinheim and has established a substantial academic profile within cardiovascular and health professions research. According to available scholarly metrics, the researcher has authored numerous publications, accumulated significant citation impact, and achieved a notable h-index. The recognized publication reflects continued engagement with translational clinical research aimed at improving diagnostic and therapeutic approaches in vascular medicine.[1]

Scientific Background

The management of femoropopliteal disease has evolved considerably through advances in imaging, device technology, and procedural techniques. Clinical investigations have demonstrated that lesion morphology, calcification, vessel diameter, and patient comorbidities significantly influence therapeutic outcomes. Research in this field seeks to optimize intervention selection while minimizing restenosis, repeat procedures, and adverse events. Consequently, systematic treatment frameworks have become increasingly important for supporting consistent and evidence-informed clinical decisions.[2]

Methodology

The publication employs a case-based systematic approach to evaluate treatment pathways for femoropopliteal lesions. Clinical scenarios are used to illustrate decision-making processes, integrating current evidence, procedural considerations, lesion assessment, and patient-specific characteristics. This methodology enables practical interpretation of available research findings while demonstrating how contemporary therapeutic options can be applied in real-world clinical environments. The approach supports both educational and clinical objectives by linking evidence with application.[2]

Key Findings

The study emphasizes that successful treatment selection depends on comprehensive lesion characterization and individualized patient evaluation. Findings indicate that modern endovascular technologies offer expanded therapeutic possibilities when integrated into structured treatment algorithms. The article further highlights the importance of balancing procedural efficiency with long-term clinical outcomes, reinforcing the value of evidence-guided intervention planning for achieving durable vascular results and improved patient care.[4]

Scientific Contributions

This publication contributes to vascular medicine by consolidating current knowledge into a clinically accessible framework that supports treatment selection for femoropopliteal disease. The article bridges scientific evidence and clinical implementation, offering insights into procedural planning, patient stratification, and therapeutic optimization. Its systematic perspective enhances understanding of contemporary intervention strategies while promoting informed decision-making across diverse healthcare settings and patient populations.[4]

Conclusion

The award-winning article provides a comprehensive examination of definitive femoropopliteal lesion treatment strategies within a modern clinical context. Through its case-based and evidence-oriented methodology, the work supports effective therapeutic decision-making and highlights the importance of individualized patient care. The publication represents a meaningful contribution to health professions research and advances ongoing efforts to improve outcomes in peripheral vascular disease management.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Grigorios Korosoglou, Author ID 6507894424. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507894424
  2. Korosoglou, G. (2026). State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic Approach. Journal of Cardiovascular Development and Disease.
    https://doi.org/10.3390/jcdd13040150
  3. MDPI. (2026). Journal of Cardiovascular Development and Disease.
    https://www.mdpi.com/journal/jcdd
  4. Atherectomy Followed by Drug-Coated Balloon Angioplasty Versus Surgery for Symptomatic Deep Femoral Artery Arteriosclerotic Disease.
    https://doi.org/10.1177/15266028241284443
  5. International Research Excellence and Best Paper Awards. (2026). Award Recognition Information.
    https://bestpaperawards.com/

Purusharth Kumar Sharma | Medicine and Dentistry | Best Researcher Award

Dr. Purusharth Kumar Sharma | Medicine and Dentistry | Best Researcher Award

Doctor | Rajasthan Dental College and Hospital | India

Dr. Purusharth Kumar Sharma is an accomplished researcher and dental professional currently pursuing his Master of Dental Surgery at Rajasthan Dental College & Hospital, Nirwan University, Jaipur, India. He has made significant contributions to medical and dental research through multiple patents, including devices for parotid tumor removal, pain level detection in dental procedures, and advanced MRI scanning for enhanced soft tissue imaging. His published books cover interdisciplinary innovations linking dentistry, neurology, and cardiology. Dr. Sharma’s research work focuses on cardiovascular diseases, cancer, and oral health, with numerous presentations at prestigious national and international conferences such as IISc Bangalore and Jawaharlal Nehru University. His scholarly impact is demonstrated by 146 Google Scholar citations, an h-index of 6, and i10-index of 6. He has received multiple awards, including the Best Paper Award for glioblastoma research and the Certificate of Excellence for cardiovascular disease prevention studies. He has earned over 40 national and international certifications, including from Stanford University, American Heart Association, Royal College of Physicians (Edinburgh and London), American College of Cardiology, and European medical boards. He holds memberships in more than 30 prestigious medical and research associations such as ACC, AHA, ESC, UNESCO, AACR, and ISCP. His publication record spans reputed journals, including Indian Heart Journal and the Journal of Cardiovascular Medicine and Therapeutics, with contributions in atherosclerosis, cardiac arrest, and drug compound development for long QT syndrome and glioblastoma. Additionally, his editorial board memberships and academic engagement reflect a strong commitment to research dissemination and knowledge advancement. With his extensive multidisciplinary achievements, active research output, international collaborations, and academic leadership, Dr. Purusharth Kumar Sharma demonstrates strong suitability for recognition as a Best Researcher Award recipient.

Profile: Google Scholar

Featured Publications

Sharma, P. K. (2019). Atherosclerosis. International Journal of Biotechnology and Biomedical Sciences, 5(1), 75–75. Krishi Sanskriti Publications.

Sharma, P. K. (2020). Cardiac arrest. International Journal of Basic and Applied Biology, 7(1), 53–53. Krishi Sanskriti Publications.

Sharma, P. K. (2020). Atherosclerosis. Journal of the Association of Physicians of India, 68(1), 56.

Sharma, P. K. (2024). Composition of new compound for the treatment of Long QT Syndrome. Indian Heart Journal, 76(Supplement 2), S27.

Sharma, P. K. (2024). Composition of drug compound for glioblastoma. International Journal of Medicine.